GLOBAL UPDATES

Settlement could make EpiPen cheaper, more accessible in New Mexico

Global Analysis by Policy Wire: SANTA FE, N.M. — A new settlement between the State of New Mexico and the maker of EpiPen is expected to make the EpiPen more accessible and affordable in the state....

Editorial Desk

April 16, 2026 One Min Read

Global Analysis by Policy Wire:

SANTA FE, N.M. — A new settlement between the State of New Mexico and the maker of EpiPen is expected to make the EpiPen more accessible and affordable in the state.

Drugmaker Mylan, Inc., agreed to pay $2.25 million to the state. It’ll resolve claims that they engaged in unfair and anticompetitive practices related to its products that are used for emergency allergic reactions.

As a…

Source: Read the full story on Policy Wire

Author

Editorial Desk

Policy Wire is your go-to editorial hub for insightful perspectives and informed analysis on pressing policy issues, both regionally and globally. Over the years, Policy Wire has collaborated with leading international news agencies—including AFP, AP, Reuters, and others—to provide fact-based reporting and nuanced commentary. With a commitment to clarity and credibility, we aim to bridge the gap between complex policy debates and public understanding, ensuring that our readers stay informed on the issues shaping the world today.